Campbell Vyvyan 4
4 · PetLife Pharmaceuticals, Inc. · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Campbell Vyvyan
Director10% Owner
Transactions
- Other
Series A Preferred Stock
2017-08-17+1,000,000→ 1,000,000 total - Other
Common Stock
2017-08-17−1,000,000→ 1,000,000 total
Footnotes (1)
- [F1]Conversion of common stock into Series A preferred stock on a 1:1 basis.